03 Aug Register Now for RSV National Expert Program
You’re invited to join the RSV National Expert Program to learn about a new FDA-approved option for infant RSV prevention:
Spotlight on BeyfortusThis 1-hour live panel discussion includes a scientific presentation followed by an interactive Q&A session with the opportunity to submit questions live. August 16th 7:00 p.m. ET and 7:00 p.m. PT Indication Beyfortus is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in:
|